🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

😧 An uncertain future for #infectiousdiseases? 📄New in CID 📲 academic.oup.com/cid/article/64… via IDSA Carlos del Rio SHEA Infection Control & Hospital Epidemiology

New: peg-interferon + nucleotide therapy for patients with chronic #hepB and low viral load - a randomised trial thelancet.com/journals/langa…

#Vaccini - Ecco cosa cambia con il decreto sull'obbligo goo.gl/50uQJi

New online: Bedaquiline in people with extensively drug-resistant tuberculosis thelancet.com/journals/lanin…

#HCV Ag quantification as a one-step procedure in diagnosing chronic #HepC infection in #Cameroon (ANRS 12336 study)→ow.ly/jPOu30bYtvz

Evidence-based recommendations on the management of extrahepatic manifestations of chronic #HCV infection bit.ly/2lZHKdt #Hepatitis

Durability of response after #HBsAg seroclearance during NA tx in chronic #HBV pts: Results after tx cessation→ow.ly/RV5430ciMOt #HepB

Free #PrEP training. In 3 days, EACS launches a new online course on PrEP - Sign up today! goo.gl/2BRSVd

#HCC decreases the chance of successful #HCV therapy with direct-acting antivirals bit.ly/2kZ0Rny #cancer #hepatitis #HepC

No evidence of #HBV reactivation in pts with resolved infection treated with DAAs in a large real-world #HCV cohort→ow.ly/Ggxv30cJF5H

aasld.org/about-aasld/pr…

Another critique The Lancet thelancet.com/journals/lance… of Cochrane review of DAAs against #HepC ncbi.nlm.nih.gov/pubmed/2858531…

Special Article: Implementation of Medical Homes in Federally Qualified Health Centers nej.md/2sTFWX3 #primarycare

"Screening for HIV in primary care is cost-effective" The Lancet paper on #r4today #HIV #screening #primarycare thelancet.com/journals/lanhi…

Britain's loss, Europe's gain: European Medicines Agency (EMA) prepares to move from London to continental Europe thelancet.com/journals/lance…

TDF may be stopped in some HBeAg negative #HBV subjects after pronlonged suppressive therapy. Need to define optimal candidates and timing. x.com/jhepatology/st…

[In press] #HCC risk following DAA #HCV therapy: A systematic review, meta-analyses, and meta-regression bit.ly/2vQMsP1

Evaluation of #HCC Response to Locoregional Therapy: Validation of MRI-Based Response Criteria vs Explant #Pathology bit.ly/2uWKxox

#HCV #eradication induced by direct-acting #antiviral agents reduces the risk of #hepatocellular #carcinoma bit.ly/2f2CqB6 #HepC #hepatitisC #cancer #livercancer #DAA